Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Los Angeles, California and other locations
Dates
study started
completion around

Description

Summary

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

Official Title

A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors

Details

Keywords

Germ Cell Tumor, Metachronous Malignant Neoplasm, Seminoma, Stage I Testicular Cancer AJCC V8, Stage IA Testicular Cancer AJCC V8, Stage IB Testicular Cancer AJCC V8, Stage is Testicular Cancer AJCC V8, Germ Cell and Embryonal Neoplasms, Neoplasms, Testicular Neoplasms, Biomarker Analysis, Blood Product Collection

Eligibility

Locations

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
SWOG Cancer Research Network
ID
NCT04435756
Study Type
Observational
Participants
Expecting 956 study participants
Last Updated